Vietnam Authority To Manage Drugs To Curb Price Fluctuations
This article was originally published in PharmAsia News
Vietnam's Drug Administration Department says it intends to manage the prices of all drugs, imported and domestic, in an effort to control the fluctuation of prices this year. The department vowed prices would be managed in all phases of the pricing process, from production and importation to wholesale and retail sales. Vietnam authorities said prices would be based on production costs, incorporating the cost of materials and distribution of the products. Import prices would be based on importing costs, transportation and management costs and profits, the department said. (click here for more
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.